Management of migraine in children and adolescents: A systematic review of guidelines and practice recommendations

BackgroundHigh-quality research studies on therapeutic approaches for migraine management in pediatrics are scarce. Therefore, we conducted a systematic review of current clinical practice guidelines for the diagnosis and management of migraine in children and adolescents to identify areas of consensus and disagreement, as well as critical gaps, paving the way for future updates and improvements.MethodsWe searched PubMed, WOS, and SCOPUS for guidelines published in the English language in the last 10 years focused on the diagnosis and management of migraine in children and adolescents.ResultsFollowing a systematic search, eight eligible guidelines were identified. These guidelines were authored by the American Academy of Neurology (AAN), the European Headache Federation/European Academy of Neurology (EHF/EAN), the International Headache Society (IHS), National Institute for Health and Care Excellence (NICE), the Danish Headache Society, and the German Migraine and Headache Society and the German Society of Neurology. There was a broad consensus on considering the International Classification of Headache Disorders-3rd edition as the diagnostic reference. As regards management, paracetamol and ibuprofen were considered first line in the acute management of migraine, with sumatriptan and zolmitriptan nasal sprays rated as second line. Injectable medications for acute management were overlooked in most guidelines. On the other hand, targeted age groups, dosing, and preventive treatment choices showed areas of variability. Various non-pharmacological measures gained attention in all guidelines. Notably, CGRP antagonists and non-invasive neuromodulation techniques were identified as major gaps.ConclusionThe current systematic review highlights areas of agreement and disagreement between existing guidelines on the management of childhood and adolescent migraine and emphasizes the current gaps and opportunities, thus offering a solid foundation for future studies and guidelines.

Authors

Institutions

Publication Details

Journal
Cephalalgia
Published
2026-02-01
DOI
https://doi.org/10.1177/03331024251413283
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of migraine in children and adolescents: A systematic review of guidelines and practice recommendations

Alaa Elmazny, Amr K. Hassan, Rehab Magdy, Ahmed H. Dahshan et al.
Cephalalgia
Migraine and Headache Studies
article

Management of migraine in children and adolescents: A systematic review of guidelines and practice recommendations

Alaa Elmazny, Amr K. Hassan, Rehab Magdy, Ahmed H. Dahshan, Mário Fernando Prieto Peres, Francesca Puledda, Anas Elgenidi, Mona Hussein, Ishaq Abu-Arafeh, Aynur Ozge, Cristina Tassorelli
article en

Abstract

BackgroundHigh-quality research studies on therapeutic approaches for migraine management in pediatrics are scarce. Therefore, we conducted a systematic review of current clinical practice guidelines for the diagnosis and management of migraine in children and adolescents to identify areas of consensus and disagreement, as well as critical gaps, paving the way for future updates and improvements.MethodsWe searched PubMed, WOS, and SCOPUS for guidelines published in the English language in the last 10 years focused on the diagnosis and management of migraine in children and adolescents.ResultsFollowing a systematic search, eight eligible guidelines were identified. These guidelines were authored by the American Academy of Neurology (AAN), the European Headache Federation/European Academy of Neurology (EHF/EAN), the International Headache Society (IHS), National Institute for Health and Care Excellence (NICE), the Danish Headache Society, and the German Migraine and Headache Society and the German Society of Neurology. There was a broad consensus on considering the International Classification of Headache Disorders-3rd edition as the diagnostic reference. As regards management, paracetamol and ibuprofen were considered first line in the acute management of migraine, with sumatriptan and zolmitriptan nasal sprays rated as second line. Injectable medications for acute management were overlooked in most guidelines. On the other hand, targeted age groups, dosing, and preventive treatment choices showed areas of variability. Various non-pharmacological measures gained attention in all guidelines. Notably, CGRP antagonists and non-invasive neuromodulation techniques were identified as major gaps.ConclusionThe current systematic review highlights areas of agreement and disagreement between existing guidelines on the management of childhood and adolescent migraine and emphasizes the current gaps and opportunities, thus offering a solid foundation for future studies and guidelines.

CephalalgiaVol. 46(2)
Beni-Suef University (EG), Cairo University (EG), King's College London (GB), University of Pavia (IT), Hospital Israelita Albert Einstein (BR), Royal Hospital for Children (GB), National Institute for Health and Care Research (GB), Royal Hospital for Sick Children (GB), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Mayo Clinic in Florida (US), Mersin Üniversitesi (TR), Arabian Gulf University (BH), Turkish Atomic Energy Authority (TR)
Openalex Percentile: Top 56%
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.